Yatharth Hospital & Trauma Care Services Limited Share Price & Analysis

₹945.50−0.86%Updated 28 Oct 2026, 03:30 pm IST

LTP

₹945.50−0.86%

Open

₹940.00

High

₹963.40

Low

₹936.60

₹945.50

52W High

₹1184.00

52W Low

₹538.00

Volume

247K

Lot Size

Sector

Healthcare

Market Cap

₹9K Cr

Face Value

₹10

Mid Cap

Price Chart

Candle

Range

Patterns

Fundamentals

P/E

49.60

Sector P/E

50.20

P/B

4.64

EPS

₹18.24

ROE

10.20%

ROCE

12.90%

D/E Ratio

0.15

Div Yield

0.05%

Book Value

₹185.00

Strengths

Low debt relative to equity (D/E 0.2x)

Concerns

Peer Comparison

Company	CMP	Mkt Cap	P/E	P/B	ROE %	ROCE %	D/E
SUNPHARMA Sun Pharmaceutical Industries Limited	₹1,758	₹4.2L Cr	33.2	5.05	16	20.5	0.07
DIVISLAB Divi's Laboratories Limited	₹9,559	₹2.4L Cr	79.8	15.15	16.5	22	0.01
TORNTPHARM Torrent Pharmaceuticals Limited	₹4,557	₹1.7L Cr	79.3	9.43	27.4	15.2	0.77
ZYDUSLIFE Zydus Lifesciences Limited	₹1,176	₹1.1L Cr	23.1	4.37	21.2	21.1	0.38
APOLLOHOSP Apollo Hospitals Enterprise Limited	₹8,137	₹1.1L Cr	52.8	12.35	21.2	17.4	0.88
CIPLA Cipla Limited	₹1,366	₹1.1L Cr	30.2	3.21	11.6	15.5	0.01
LAURUSLABS Laurus Labs Limited	₹2,182	₹1.1L Cr	97.4	22.22	18.3	17.8	0.46

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

YATHARTH · as of Mar 2026

Promoters61.64%0.20pp

FII4.45%5.33pp

DII13.56%2.06pp

Public20.35%3.08pp

Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	66.44%	66.54%	66.54%	66.54%	61.44%	61.64%
FII	2.59%	3.99%	4.90%	6.28%	9.78%	4.45%
DII	8.81%	9.30%	9.40%	6.97%	11.50%	13.56%
Public	22.15%	20.15%	19.16%	20.20%	17.27%	20.35%

Corporate Events

To consider and approve the Unaudited Financial Results for Q2FY27.

Results2 Nov 2026

To consider Fund raising by way of Issuance of equity shares or other securities.

Event16 Sept 2026

Interim Dividend - Re 0.50 Per Share

Dividend13 Aug 2026

To consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the period ended Jun 30, 2026, dividend and other business matters.

Dividend9 Aug 2026

Annual General Meeting

AGM20 Sept 2023

Latest News

All news

Yatharth Hospital board meets; no major announcements.

*Yatharth Hospital board meets; no major announcements.* The board met on September 17, 2026, to discuss routine matters. No disclosures on earnings, appointments, or strategic moves were made. The filing indicates standard corporate compliance. 📊 *STOCKS:* $YATHARTH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #BoardMeeting

NSE Filing17 Sept

High Impact

Yatharth Hospital files press release with no financial details

*Yatharth Hospital files press release with no financial details.* The submission to NSE is marked as a corporate filing but contains no material financial or operational updates. Traders should await further clarity. 📊 *STOCKS:* | 🏢 *SECTOR:* Corporate | #LOWIMPACT #Filing

NSE Filing17 Sept

Low Impact

Aster, Advent eye Yatharth Hospitals in healthcare consolidation

*Aster, Advent eye Yatharth Hospitals in healthcare consolidation* as sector consolidation gains momentum. Both private players are reportedly in advanced talks to acquire stakes in Yatharth, a leading hospital chain in North India. The move signals growing investor confidence in healthcare infrastructure. Deal values could exceed **₹500 crore**, pending final terms. 📊 *STOCKS:* | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Healthcare

The Economic Times28 Aug

Medium Impact

Yatharth Hospital announces investor presentation event

*Yatharth Hospital announces investor presentation event*. Yatharth Hospital & Trauma Care Services Limited has informed the NSE about an upcoming investor presentation. The event aims to provide updates on business performance and strategic initiatives. No financial figures or major announcements were disclosed. 📊 *STOCKS:* $YATHARTH | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #InvestorEvent

NSE Filing11 Aug

Low Impact

Yatharth Hospital grants ESOPs under 2024 scheme

*Yatharth Hospital grants ESOPs under 2024 scheme.* The company has issued employee stock options as part of its ESOP-2024 plan. This move aims to incentivize key personnel and align employee interests with long-term growth. While not impacting immediate financials, it signals internal confidence in future performance. 📊 *STOCKS:* $YATHARTH | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #ESOP

NSE Filing10 Aug

Low Impact

Yatharth Hospitals added to MSCI India Small Cap Index

*Yatharth Hospitals added to MSCI India Small Cap Index.* This inclusion is expected to boost investor visibility and potentially drive passive fund inflows. SEBI analysts have set a target price of **₹850**, indicating strong upside potential. Index rebalancing typically enhances trading liquidity for small-cap stocks. 📊 *STOCKS:* YATHARTH | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #indexinclusion

MSN25 Apr

Medium Impact

Financials

Quarterly Results

Metric	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Revenue	₹342 Cr 6.9%	₹320 Cr 14.7%	₹279 Cr 8.1%	₹258 Cr 11.2%	₹232 Cr 5.9%	₹219 Cr 0.5%	₹218 Cr 2.8%	₹212 Cr
Op. Profit	₹80 Cr 8.1%	₹74 Cr 13.8%	₹65 Cr 1.6%	₹64 Cr 12.3%	₹57 Cr 3.6%	₹55 Cr 0.0%	₹55 Cr 1.9%	₹54 Cr
OPM	23.0% 0.0%	23.0% 0.0%	23.0% 8.0%	25.0% 0.0%	25.0% 0.0%	25.0% 0.0%	25.0% 0.0%	25.0%
Net Profit	₹45 Cr 4.7%	₹43 Cr 4.9%	₹41 Cr 2.4%	₹42 Cr 7.7%	₹39 Cr 30.0%	₹30 Cr 3.2%	₹31 Cr 3.3%	₹30 Cr
EPS (₹)	4.93 4.7%	4.71 10.0%	4.28 1.8%	4.36 8.5%	4.02 27.2%	3.16 12.5%	3.61 2.0%	3.54

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Revenue	₹1.2K Cr 36.2%	₹886 Cr 39.5%	₹635 Cr 32.8%	₹478 Cr 27.5%	₹375 Cr 74.4%	₹215 Cr 58.1%	₹136 Cr 49.5%	₹91 Cr 16.7%	₹78 Cr 9.9%	₹71 Cr
Expenses	₹902 Cr 37.7%	₹655 Cr 44.6%	₹453 Cr 32.1%	₹343 Cr 30.4%	₹263 Cr 78.9%	₹147 Cr 50.0%	₹98 Cr 38.0%	₹71 Cr 18.3%	₹60 Cr 13.2%	₹53 Cr
Op. Profit	₹305 Cr 32.6%	₹230 Cr 26.4%	₹182 Cr 34.8%	₹135 Cr 20.5%	₹112 Cr 64.7%	₹68 Cr 78.9%	₹38 Cr 90.0%	₹20 Cr 11.1%	₹18 Cr 0.0%	₹18 Cr
OPM	25.0% 3.8%	26.0% 10.3%	29.0% 3.6%	28.0% 6.7%	30.0% 6.3%	32.0% 14.3%	28.0% 27.3%	22.0% 8.3%	24.0% 4.0%	25.0%
Other Income	₹25 Cr 127.3%	₹11 Cr 31.3%	₹16 Cr 433.3%	₹3 Cr 50.0%	₹2 Cr 100.0%	₹1 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Interest	₹19 Cr 58.3%	₹12 Cr 9.1%	₹11 Cr 52.2%	₹23 Cr 0.0%	₹23 Cr 15.0%	₹20 Cr 0.0%	₹20 Cr 185.7%	₹7 Cr 40.0%	₹5 Cr 16.7%	₹6 Cr
Depreciation	₹88 Cr 54.4%	₹57 Cr 96.6%	₹29 Cr 3.6%	₹28 Cr 0.0%	₹28 Cr 33.3%	₹21 Cr 0.0%	₹21 Cr 162.5%	₹8 Cr 33.3%	₹6 Cr 14.3%	₹7 Cr
PBT	₹224 Cr 30.2%	₹172 Cr 9.6%	₹157 Cr 78.4%	₹88 Cr 39.7%	₹63 Cr 125.0%	₹28 Cr 1500.0%	₹-2 Cr 140.0%	₹5 Cr 37.5%	₹8 Cr 60.0%	₹5 Cr
Tax %	24.0% 0.0%	24.0% 11.1%	27.0% 8.0%	25.0% 16.7%	30.0% 0.0%	30.0% 266.7%	-18.0% 185.7%	21.0% 8.7%	23.0% 43.9%	41.0%
Net Profit	₹170 Cr 29.8%	₹131 Cr 14.9%	₹114 Cr 72.7%	₹66 Cr 50.0%	₹44 Cr 120.0%	₹20 Cr 1100.0%	₹-2 Cr 150.0%	₹4 Cr 33.3%	₹6 Cr 100.0%	₹3 Cr
EPS (₹)	18.2 34.3%	13.55 1.7%	13.33 32.8%	10.04 49.0%	6.74 143.3%	2.77 1485.0%	-0.2 132.8%	0.61 35.1%	0.94 57.5%	2.21
Div Payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Liabilities
Equity Capital	₹96 Cr 0.0%	₹96 Cr 11.6%	₹86 Cr 30.3%	₹66 Cr 0.0%	₹66 Cr 312.5%	₹16 Cr 0.0%	₹16 Cr 0.0%	₹16 Cr 0.0%	₹16 Cr 14.3%	₹14 Cr
Reserves	₹1.7K Cr 11.6%	₹1.5K Cr 91.5%	₹788 Cr 573.5%	₹117 Cr 129.4%	₹51 Cr 8.9%	₹56 Cr 47.4%	₹38 Cr 2.6%	₹39 Cr 4.9%	₹41 Cr 41.4%	₹29 Cr
Borrowings	₹264 Cr 2100.0%	₹12 Cr 85.9%	₹85 Cr 68.2%	₹267 Cr 1.1%	₹264 Cr 36.8%	₹193 Cr 0.5%	₹194 Cr 10.9%	₹175 Cr 40.0%	₹125 Cr 47.1%	₹85 Cr
Other Liabilities	₹218 Cr 91.2%	₹114 Cr 90.0%	₹60 Cr 66.7%	₹36 Cr 20.0%	₹45 Cr 4.7%	₹43 Cr 10.3%	₹39 Cr 50.0%	₹26 Cr 136.4%	₹11 Cr 10.0%	₹10 Cr
Total Liabilities	₹2.3K Cr 30.7%	₹1.7K Cr 69.9%	₹1.0K Cr 109.7%	₹486 Cr 14.1%	₹426 Cr 37.9%	₹309 Cr 7.7%	₹287 Cr 11.7%	₹257 Cr 33.2%	₹193 Cr 39.9%	₹138 Cr
Assets
Fixed Assets	₹1.3K Cr 106.6%	₹605 Cr 36.9%	₹442 Cr 47.8%	₹299 Cr 1.3%	₹303 Cr 20.7%	₹251 Cr 32.8%	₹189 Cr 15.2%	₹164 Cr 209.4%	₹53 Cr 1.9%	₹54 Cr
CWIP	₹102 Cr 54.1%	₹222 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr 100.0%	₹62 Cr 4.6%	₹65 Cr 40.9%	₹110 Cr 71.9%	₹64 Cr
Investments	₹2 Cr 97.3%	₹74 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Other Assets	₹909 Cr 9.7%	₹829 Cr 43.7%	₹577 Cr 208.6%	₹187 Cr 52.0%	₹123 Cr 112.1%	₹58 Cr 61.1%	₹36 Cr 33.3%	₹27 Cr 10.0%	₹30 Cr 50.0%	₹20 Cr
Total Assets	₹2.3K Cr 30.7%	₹1.7K Cr 69.9%	₹1.0K Cr 109.7%	₹486 Cr 14.1%	₹426 Cr 37.9%	₹309 Cr 7.7%	₹287 Cr 11.7%	₹257 Cr 33.2%	₹193 Cr 39.9%	₹138 Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Operating CF	₹205 Cr 56.5%	₹131 Cr 4466.7%	₹-3 Cr 104.7%	₹64 Cr 6.7%	₹60 Cr 36.4%	₹44 Cr 12.8%	₹39 Cr 129.4%	₹17 Cr 0.0%	₹17 Cr 32.0%	₹25 Cr
Investing CF	₹-598 Cr 54.1%	₹-388 Cr 71.7%	₹-226 Cr 1030.0%	₹-20 Cr 61.5%	₹-52 Cr 147.6%	₹-21 Cr 51.2%	₹-43 Cr 44.9%	₹-78 Cr 52.9%	₹-51 Cr 2.0%	₹-50 Cr
Financing CF	₹254 Cr 50.1%	₹509 Cr 67.4%	₹304 Cr 1788.9%	₹-18 Cr 1700.0%	₹-1 Cr 94.7%	₹-19 Cr 480.0%	₹5 Cr 89.4%	₹47 Cr 9.3%	₹43 Cr 65.4%	₹26 Cr
Net Cash Flow	₹-140 Cr 155.3%	₹253 Cr 237.3%	₹75 Cr 188.5%	₹26 Cr 271.4%	₹7 Cr 133.3%	₹3 Cr 200.0%	₹1 Cr 107.7%	₹-13 Cr 244.4%	₹9 Cr 800.0%	₹1 Cr
Free Cash Flow	₹-112 Cr 34.5%	₹-171 Cr 78.1%	₹-96 Cr 318.2%	₹44 Cr 109.5%	₹21 Cr 12.5%	₹24 Cr 700.0%	₹-4 Cr 93.3%	₹-60 Cr 475.0%	₹16 Cr 33.3%	₹24 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Debtor Days	113d 8.9%	124d 5.3%	131d 59.8%	82d 1.2%	83d 33.9%	62d 37.8%	45d 6.3%	48d 9.1%	44d 24.1%	58d
Inventory Days	32d 25.6%	43d	—	—	—	—	72d 18.2%	88d 109.5%	42d 10.6%	47d
Days Payable	171d 185.0%	60d	—	—	—	—	347d 29.2%	490d 362.3%	106d 16.5%	127d
Cash Conv. Cycle	-26d 124.3%	107d 18.3%	131d 59.8%	82d 1.2%	83d 33.9%	62d 127.1%	-229d 35.3%	-354d 1670.0%	-20d 9.1%	-22d
Working Capital Days	80d 24.5%	106d 10.2%	118d 306.9%	29d	0d 100.0%	-18d 79.8%	-89d 18.7%	-75d 358.6%	29d 34.1%	44d
ROCE	13.0% 7.1%	14.0% 41.7%	24.0% 11.1%	27.0% 3.8%	26.0% 44.4%	18.0% 157.1%	7.0% 16.7%	6.0% 25.0%	8.0%	—

Source: Screener.in · Lower days = better efficiency

Same Sector

ALKEMAlkem Laboratories LimitedNeutral APOLLOHOSPApollo Hospitals Enterprise LimitedNeutral AUROPHARMAAurobindo Pharma LimitedNeutral BIOCONBiocon LimitedNeutral CIPLACipla LimitedNeutral

Frequently Asked Questions

What is Yatharth Hospital & Trauma Care Services Limited share price today?

Yatharth Hospital & Trauma Care Services Limited (YATHARTH) is currently trading at ₹945.5 on NSE, down 0.86% as of the last market session. Prices update daily after market close on MarketNetra.

Is Yatharth Hospital & Trauma Care Services Limited available in F&O (Futures & Options)?

Yes, Yatharth Hospital & Trauma Care Services Limited (YATHARTH) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.

What is Yatharth Hospital & Trauma Care Services Limited 52-week high and low?

Yatharth Hospital & Trauma Care Services Limited's 52-week high is ₹1,184 and the 52-week low is ₹538. The current price of ₹945.5 is 20.1% below the 52W high.

What is Yatharth Hospital & Trauma Care Services Limited P/E ratio?

Yatharth Hospital & Trauma Care Services Limited's current P/E ratio is 49.6. This indicates the market is paying ₹49.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.

How to trade Yatharth Hospital & Trauma Care Services Limited options?

Yatharth Hospital & Trauma Care Services Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade YATHARTH options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.

Yatharth Hospital & Trauma Care Services Limited Share Price & Analysis

Price Chart

Fundamentals

Peer Comparison

Shareholding Pattern

Corporate Events

Latest News

Financials

Quarterly Results

Annual Profit & Loss

Balance Sheet

Cash Flow Statement

Key Ratios History

Related Analysis

Same Sector

Frequently Asked Questions